Loading…
Loading…
Sentiment · FY2026 Q1
| Analyst | Firm | Questions | ChallengePercentage of questions scored as challenging — where the analyst pushed back, pressed for specifics, or questioned management's assumptions. |
|---|---|---|---|
| Ron Kamdem | Morgan Stanley | 12 | 0% |
| Juan Sanabria | BMO Capital Markets | 12 | 0% |
| Mike Carroll | RBC Capital Markets | 12 | 17% |
| Mike Stroyeck | Green Street | 10 | 0% |
| Vikram Malhotra | Mizuho Securities | 10 | 0% |
| John Kilichowski | Wells Fargo | 9 | 22% |
| Rich Anderson | Wedbush Securities | 9 | 22% |
| Nick Joseph | Citigroup | 8 | 0% |
| Jim Kammert | Evercore ISI | 8 | 0% |
| Omotayo Okusanya | Deutsche Bank | 8 | 25% |
| Firm | Analysts | Questions | ChallengePercentage of questions scored as challenging — where the analyst pushed back, pressed for specifics, or questioned management's assumptions. |
|---|---|---|---|
| BMO Capital Markets | 1 | 12 | 0% |
| Green Street | 2 | 12 | 0% |
| Mizuho Securities | 2 | 12 | 0% |
| Morgan Stanley |
| 1 |
| 12 |
| 0% |
| RBC Capital Markets | 1 | 12 | 17% |
| Citigroup | 2 | 10 | 0% |
| Bank of America | 2 | 10 | 0% |
| Wedbush Securities | 1 | 9 | 22% |
Ventas delivered Q1 normalized FFO of $0.94 per share, up 9% year-over-year, raising the full-year midpoint to $3.86 as total company same-store property-level growth reached nearly 9% and SHOP same-store NOI surged 16%. Average occupancy increased 310 basis points year-over-year to 90.4%, and senior housing investment accelerated as demographic demand and supply constraints created a multi-year tailwind. Revenue and pricing momentum continued building across the portfolio, and balance sheet and liquidity strength supported the investment thesis.
Revenue Growth | M&A | Capital Allocation | Competitive Dynamics | Subscriber Growth | Demand | Pricing | Capex Investment | |
|---|---|---|---|---|---|---|---|---|
| 2024Q4 | 9 | 9 | 8 | 6 | 6 | 4 | 3 | 2 |
| 2025Q1 | 12 | 4 | 5 | 5 | 7 | 5 | 4 | |
| 2025Q2 | 11 | 4 | 5 | 3 | 8 | 1 | 4 | 1 |
| 2025Q3 | 7 | 7 | 8 | 7 | 4 | 3 | 2 | 1 |
| 2025Q4 | 5 | 9 | 9 | 4 | 6 | 4 | 4 | 1 |
| 2026Q1 | 4 | 8 | 4 | 13 | 8 | 4 | 8 |
| '24Q4 | '25Q1 | '25Q2 | '25Q3 | '25Q4 | '26Q1 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 9 | 12 | 11 | 7 | 5 | 4 |
| M&A | 9 | 4 | 4 | 7 | 9 | 8 |
| Capital Allocation | 8 | 5 | 5 | 8 | 9 | 4 |
| Competitive Dynamics | 6 | 5 | 3 | 7 | 4 | 13 |
| Subscriber Growth | 6 | 7 | 8 | 4 | 6 | |
| Demand | 4 | 5 | 1 | 3 | 4 | 8 |
| Pricing | 3 | 4 | 4 | 2 | 4 | 4 |
| Capex Investment | 2 | 1 | 1 | 1 | 8 |
| Company | Score | Trend | Rev YoY |
|---|---|---|---|
VTR Ventas | 8 | +22.0% | |
| DOC Healthpeak Properties | 6 | +7.1% | |
| WELL Welltower | 8 | +40.3% |